美国正研发新冠疫苗, 美国共和党国会参议院领袖可能推出新抗疫纾困法案

In 每日市场分析
May 27, 2020

美国正研发新冠疫苗
美国大型药厂宣布,正研究两种潜在的新冠病毒疫苗及一种针对冠状病毒的实验性药物,作为收购奥地利制造商交易的一部分,该公司同时收购了一种实验性疫苗,并合作开发第二种候选疫苗及潜在药物。此外,亦指出候选疫苗将使用技术是以其埃博拉扎伊尔病毒疫苗作为基础,是首个被批准使用於人类的 rVSV 疫苗。目前全球有逾 100 个新冠疫苗研发计划,增加市场对疫苗年内面世的憧憬,提振市场气氛。

美国共和党国会参议院领袖可能推出新抗疫纾困法案
美国共和党国会参议院领袖麦康奈尔表示,美国多个州重启经济後的表现,将有助国会评估是否需要推出新一份抗疫纾困法案。并指如有需要将会继续为有需要的人仕提供失业救济金。言论增加市场对美国政府未来推出更多刺激经济方案的憧憬。

————————————
Z. com Bullion为日本上市集团GMO Financial Holdings, Inc 旗下关联公司。杠杆式保证金交易存在高风险 , 有关风险请浏览公司网站https://bullion.z.com/tc/about/legal/risk/

場外式黃金/白銀交易的風險:
Service relating to Over-the-counter (OTC) Gold Bullion/Silver trading is provided by MOL. OTC Gold/Silver Bullion trading carries a high degree of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. OTC Gold/Silver Bullion is not regulated by the Securities and Futures Commission (""SFC"") and therefore trading OTC Gold/Silver Bullion will not be subject to rules or regulations promulgated by the SFC. Before deciding to trade OTC Gold/Silver Bullion you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain losses in excess of your deposited fund or even more in extreme circumstances and therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading OTC Gold/Silver Bullion, and seek advice from an independent financial advisor if you require.